Ten Capital Wealth Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-188
Closed -$13K 478
2022
Q1
$13K Buy
188
+79
+72% +$5.78K 0.01% 264
2021
Q4
$8K Hold
109
﹤0.01% 322
2021
Q3
$10K Hold
109
﹤0.01% 268
2021
Q2
$14K Hold
109
﹤0.01% 276
2021
Q1
$14K Hold
109
﹤0.01% 243
2020
Q4
$14K Buy
+109
New +$13.2K ﹤0.01% 236

Other funds holding EXAS

Ten Capital Wealth Advisors's EXAS Position: Q2 2022 in Review

Ten Capital Wealth Advisors sold out of Exact Sciences (EXAS) in Q2 2022, closing a stake of 188 shares — an estimated $13K sold.

Ten Capital Wealth Advisors first reported a position in EXAS in Q4 2020 and held it in 6 quarters. The position peaked at $14K in Q2 2021. 501 funds tracked by Wall St. Rank hold EXAS as of Q2 2022.

  • Ten Capital Wealth Advisors reported no remaining Exact Sciences position as of Q2 2022 after selling out during the quarter.
  • Ten Capital Wealth Advisors sold 188 Exact Sciences shares in Q2 2022, an estimated $13K.
  • Ten Capital Wealth Advisors first reported a position in Exact Sciences in Q4 2020 and held it in 6 quarters.
  • Ten Capital Wealth Advisors's Exact Sciences position peaked at $14K in Q2 2021.
  • 501 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2022.

Based on Ten Capital Wealth Advisors's 13F filing for Q2 2022, filed 9 Aug 2022.